“The supply chain has already been stressed over the past few years, but as we go through the fall and into the winter, we’re going to have some real challenges” due to Covid-19, Michael Osterholm, the center’s director, told STAT.
Forty-three percent, or 67 out of 156, of acute critical care drugs are in shortage, including antibiotics, blood thinners and sedatives, according to the center.
Experts predict a fivefold jump in demand for midazolam, a common sedative, and a tenfold increase in the use of cisatracurium, a muscle relaxant, STAT reported.
They also predict more COVID-19 hot spots to pop up.
“This time, we may approach a surge not with five or six hot spots, but maybe something like 30 or more hot spots,” Stephen Schondelmeyer, another co-principal investigator at the center, told STAT. “If they’re all having a surge at the same time, we don’t have the ability to shift supplies around as we tried to do in the spring.”
Read the full report here.
More articles on pharmacy:
Participant in AstraZeneca’s Brazil COVID-19 trial who died didn’t get vaccine
12 drugs being tested as COVID-19 treatments
Trump’s $200 Medicare drug card plan may violate election law, HHS lawyer says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
